Table 1.
Comparison of demographic, clinical and laboratory findings among different ACE gene polymorphisms.
Table 2.
Comparison of ACE level of the patients with different demographic and clinical findings, and correlation of ACE levels with other parameters*.
Table 3.
Comparison of demographic, clinical and laboratory findings according to disease severity.
Table 4.
Comparison of demographic, clinical and laboratory parameters according to mortality or ICU admission.
Fig 1.
CRP, C-reactive protein; NLR, neutrophil/lymphocyte ratio; LDH, lactate dehydrogenase; ACE, angiotensin converting enzyme.
Fig 2.
Prediction of Intensive Care Unit Admision.
CRP, C-reactive protein; NLR, neutrophil/lymphocyte ratio; ACE, angiotensin converting enzyme; CVA, cerebrovascular accident; LDH, lactate dehydrogenase.
Table 5.
Comparison of demographic, clinical and laboratory findings according to presence of HT and/or ACEi/ARB use.
Table 6.
Comparison of demographic, clinical and laboratory findings according to presence of T2DM and/or DPP4i use.
Table 7.
ROC analysis showing cutoff values for ACE levels predicting ICU admission in different patient groups.